SMTL ID : 9eah.1

Structure of nanobody AT209 in complex with the olmesartan-bound angiotensin II type I receptor (AT1R)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-1-1-mer

Ligands

1 x OLM: Olmesartan(Non-covalent)

OLM.1: 18 residues within 4Å: Chain A: Y.168, F.210, W.217, Y.220, T.221, Y.225, S.238, V.241, S.242, L.245, A.296, R.300, F.315, K.332, I.528, Y.532 Chain D: T.102, L.103 15 PLIP interactions: 14 interactions with chain A, 1 interactions with chain D Hydrophobic interactions: A:F.210, A:W.217, A:Y.225, A:V.241, A:V.241, A:L.245, A:K.332, A:I.528, A:Y.532, D:L.103 Hydrogen bonds: A:Y.168, A:Y.220, A:R.300 Salt bridges: A:R.300 pi-Cation interactions: A:K.332

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.2: 8 residues within 4Å: Chain A: L.474, M.483, A.484, L.487, F.488, F.491, F.541, L.545 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.484, A:L.487, A:F.488, A:F.491, A:F.541 Hydrogen bonds: A:L.474

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Skiba, M.A. et al., Epitope-Directed Selection of GPCR Nanobody Ligands with Evolvable Function. To Be Published

Release Date

2025-03-05

Peptides

Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562: AD
BAG2 Anti-BRIL Fab Heavy Chain: B
BAG2 Anti-BRIL Fab Light Chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

D
B

B
C

C
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562

BAG2 Anti-BRIL Fab Heavy Chain

BAG2 Anti-BRIL Fab Light Chain

Related Entries With Identical Sequence